Abstract
The Nef protein is an essential factor for lentiviral pathogenesis in humans and other simians. Despite a multitude of functions attributed to this protein, the exact role of Nef in disease progression remains unclear. One of its most intriguing functions is the ability of Nef to enhance the infectivity of viral particles. In this review we will discuss current insights in the mechanism of this well-known, yet poorly understood Nef effect. We will elaborate on effects of Nef, on both virion biogenesis and the early stage of the cellular infection, that might be involved in infectivity enhancement. In addition, we provide an overview of different HIV-1 Nef domains important for optimal infectivity and briefly discuss some possible sources of the frequent discrepancies in the field. Hereby we aim to contribute to a better understanding of this highly conserved and therapeutically attractive Nef function.
Keywords: Nef, HIV, infectivity, viral replication, mutation analysis, envelope protein, cholesterol, proteasome, NEF PROTEIN, Domain Mutations
Current HIV Research
Title: The Nef-Infectivity Enigma: Mechanisms of Enhanced Lentiviral Infection
Volume: 9 Issue: 7
Author(s): Jolien Vermeire, Griet Vanbillemont, Wojciech Witkowski and Bruno Verhasselt
Affiliation:
- Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, De Pintelaan 185, UZ Gent, B-9000 Gent, Belgium.,Belgium
Keywords: Nef, HIV, infectivity, viral replication, mutation analysis, envelope protein, cholesterol, proteasome, NEF PROTEIN, Domain Mutations
Abstract: The Nef protein is an essential factor for lentiviral pathogenesis in humans and other simians. Despite a multitude of functions attributed to this protein, the exact role of Nef in disease progression remains unclear. One of its most intriguing functions is the ability of Nef to enhance the infectivity of viral particles. In this review we will discuss current insights in the mechanism of this well-known, yet poorly understood Nef effect. We will elaborate on effects of Nef, on both virion biogenesis and the early stage of the cellular infection, that might be involved in infectivity enhancement. In addition, we provide an overview of different HIV-1 Nef domains important for optimal infectivity and briefly discuss some possible sources of the frequent discrepancies in the field. Hereby we aim to contribute to a better understanding of this highly conserved and therapeutically attractive Nef function.
Export Options
About this article
Cite this article as:
Vermeire Jolien, Vanbillemont Griet, Witkowski Wojciech and Verhasselt Bruno, The Nef-Infectivity Enigma: Mechanisms of Enhanced Lentiviral Infection, Current HIV Research 2011; 9(7) . https://dx.doi.org/10.2174/157016211798842099
DOI https://dx.doi.org/10.2174/157016211798842099 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Effects of Thiazolidinediones Beyond Glycaemic Control
Current Pharmaceutical Design Identification of Lipid Species Linked to the Progression of Non-alcoholic Fatty Liver Disease
Current Drug Targets Dynamics of Virus-Host Interplay in HIV-1 Replication
Current HIV Research Application of BRET for Studying G Protein-Coupled Receptors
Mini-Reviews in Medicinal Chemistry Potential Role of (-)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease
Current Drug Targets Antibody Penetration Into Living Cells: Pathogenic, Preventive and Immuno-Therapeutic Implications
Current Pharmaceutical Design Drug Delivery Systems for Local Anesthetics
Recent Patents on Drug Delivery & Formulation MR-Based In Vivo Analysis of Joint Biomechanics and its Relevance in the Pathogenesis of Osteoarthritis
Current Rheumatology Reviews HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol
Current Drug Targets - Cardiovascular & Hematological Disorders COVID-19 Vaccines in Clinical Trials and their Mode of Action for Immunity against the Virus
Current Pharmaceutical Design Nenatal Drug Induced Nephrotoxicity : Old and Next Generation Biomarkers for Early Detection and Management of Neonatal Drug-Induced Nephrotoxicity, with Special Emphasis on uNGAL and on Metabolomics
Current Medicinal Chemistry Nitric Oxide in Normal and Preeclamptic Pregnancy
Current Pharmaceutical Biotechnology Restoration of the Striatal Dopamine Synthesis for Parkinsons Disease:Viral Vector-Mediated Enzyme Replacement Strategy
Current Gene Therapy Exploring Mechanisms of MicroRNA Downregulation in Cancer
MicroRNA Metabolomics: A Powerful Tool to Study the Complexity of Wheat Metabolome
Protein & Peptide Letters The Potential of Selected Prostanoid Receptors as Targets in a New Therapeutic Strategy for Allergy and Immune Diseases
Current Drug Safety TRPM Channels Phosphorylation as a Potential Bridge Between Old Signals and Novel Regulatory Mechanisms of Insulin Secretion
Current Diabetes Reviews Towards Understanding the Structure-Function Relationship of Human Amyloid Disease
Current Drug Targets Transglutaminase-Catalyzed Reactions Responsible for the Pathogenesis ofCeliac Disease and Neurodegenerative Diseases: From Basic Biochemistry to Clinic
Current Medicinal Chemistry Editorial [ Hot Topic:New Methodology and Approaches to Intracellular Lipid Transport in Atherosclerosis and Cardiovascular Disease (Guest Editors: Basil D. Roufogalis and Thomas Grewal)]
Current Pharmaceutical Biotechnology